Transplante fígado 10. Referencias

1. 7 REFERÊNCIAS*
*
De acordo com: Vancouver Style (Uniform Requirements for Manuscripts Submitted to Biomedical Journals).
Abreviaturas dos títulos dos periódicos de acordo com: List of Journals Indexed in Index Medicus.

2. Referências 90
1. Detre K. Liver transplantation for chronic viral hepatitis. In: AASLD
Single Topic Conference; 1995; Reston, VA; 1995.
2. Gane EJ, Naoumov NV, Qian KP, Mondelli MU, Maertens G, Portmann
BC, et al. A longitudinal analysis of hepatitis C virus replication following
liver transplantation. Gastroenterology 1996;110(1):167-77.
3. Ferrell LD, Wright TL, Roberts J, Ascher N, Lake J. Hepatitis C viral
infection in liver transplant recipients. Hepatology 1992;16(4):865-76.
4. Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayon M, et al.
HCV-related fibrosis progression following liver transplantation: increase
in recent years. J Hepatol 2000;32(4):673-84.
5. Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl
2002;8(10 Suppl 1):S14-8.
6. Achkar JP, Araya V, Baron RL, Marsh JW, Dvorchik I, Rakela J.
Undetected hepatocellular carcinoma: clinical features and outcome
after liver transplantation. Liver Transpl Surg 1998;4(6):477-82.
7. Chung R, Katkov W, Dienstag J, Kaplan L. Chronic renal failure is
frequently associated with false-negative anti-C100 in patients with
hepatitis C viremia. Gastroenterology 1991:A729.
8. Fukumoto T, Berg T, Ku Y, Bechstein WO, Knoop M, Lemmens HP, et
al. Viral dynamics of hepatitis C early after orthotopic liver
transplantation: evidence for rapid turnover of serum virions.
Hepatology 1996;24(6):1351-4.

3. Referências 91
9. Berenguer M, Rayon JM, Prieto M, Aguilera V, Nicolas D, Ortiz V, et al.
Are posttransplantation protocol liver biopsies useful in the long term?
Liver Transpl 2001;7(9):790-6.
10. Gane EJ, Portmann BC, Naoumov N, Smith HM, Underhill JA,
Donaldson PT, et al. Long-term outcome of hepatitis C infection after
lvier transplantation. New Engl J Med 1996;334:815-20.
11. Boker KH, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, et
al. Long-term outcome of hepatitis C virus infection after liver
transplantation. Hepatology 1997;25(1):203-10.
12. Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, et al. The
course of hepatitis C virus infection after liver transplantation.
Hepatology 1994;20(5):1137-43.
13. Prieto M, Berenguer M, Rayón J, Córdoba J, Arguello L, Carrasco D, et
al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b
Infection following transplantation: relationship with rejection episodes.
Hepatology 1999;29:250-6.
14. Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS,
et al. Liver transplantation for hepatitis C: recurrence and disease
progression in 300 patients. Liver Transpl 2000;6(5):553-61.
15. Sanchez-Fueyo A, Restrepo JC, Quinto L, Bruguera M, Grande L,
Sanchez-Tapias JM, et al. Impact of the recurrence of hepatitis C virus
infection after liver transplantation on the long-term viability of the graft.
Transplantation 2002;73(1):56-63.
16. Berenguer M, Prieto M, Rayon JM, Mora J, Pastor M, Ortiz V, et al.
Natural history of clinically compensated hepatitis C virus-related graft
cirrhosis after liver transplantation. Hepatology 2000;32(4 Pt 1):852-8.

4. Referências 92
17. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The
association between hepatitis C infection and survival after orthotopic
liver transplantation. Gastroenterology 2002;122(4):889-96.
18. Pessoa MG, Wright T. Hepatitis C and transplantation. In: Cullen JH,
editor. Clinics in liver disease. Philadelphia: W.B. Sauders; 1997.
19. Schluger LK, Sheiner PA, Thung SN, Lau JY, Min A, Wolf DC, et al.
Severe recurrent cholestatic hepatitis C following orthotopic liver
transplantation. Hepatology 1996;23(5):971-6.
20. Dickson RC, Caldwell SH, Ishitani MB, Lau JY, Driscoll CJ, Stevenson
WC, et al. Clinical and histologic patterns of early graft failure due to
recurrnet hepatitis C in four patients after liver transplantation.
Transplantation 1996;61(5):701-5.
21. Taga SA, Washington MK, Terrault N, Wright TL, Somberg KA, Ferrell
LD. Cholestatic hepatitis C in liver allografts. Liver Transpl Surg
1998;4(4):304-10.
22. Hepatitis C and liver transplantation. In: First International Liver
Transplant Consensus Meeting on Hepatitis C and Liver
Transplantation; 2003; Phoenix, Arizona; 2003.
23. Davies S, Portmann B, O'Grady J, Aldis P, Chagger K, Alexander G, et
al. Hepatic histological findings after transplantation for chronic hepatitis
B virus infection, including a unique pattern of fibrosing cholestatic
hepatitis. Hepatology 1991;13:150-7.
24. Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, Batts K, Moreno-
Luna L, Poterucha J, et al. Early identification of recipients with
progressive histologic recurrence of hepatitis C after liver
transplantation. Hepatology 2000;32(5):1125-30.

5. Referências 93
25. Doughty AL, Spencer JD, Cossart YE, McCaughan GW. Cholestatic
hepatitis after liver transplantation is associated with persistently high
serum hepatitis C virus RNA levels. Liver Transpl Surg 1998;4(1):15-21.
26. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, et
al. Predictors of patient and graft survival following liver transplantation
for hepatitis C. Hepatology 1998;28(3):823-30.
27. Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, et al.
Influence of the genotypes of hepatitis C virus on the severity of
recurrent liver disease after liver transplantation. Gastroenterology
1995;108(4):1088-96.
28. Feray C, Caccamo L, Alexander GJ, Ducot B, Gugenheim J,
Casanovas T, et al. European collaborative study on factors influencing
outcome after liver transplantation for hepatitis C. European Concerted
Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology
1999;117(3):619-25.
29. Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JY, Simmonds P, et al.
Severity of liver disease in liver transplantation recipients with hepatitis
C virus infection: relationship to genotype and level of viremia.
Hepatology 1996;24(5):1041-6.
30. Vargas HE, Laskus T, Wang LF, Radkowski M, Poutous A, Lee R, et al.
The influence of hepatitis C virus genotypes on the outcome of liver
transplantation [see comments]. Liver Transpl Surg 1998;4(1):22-7.
31. Gigou M, Roque-Afonso AM, Falissard B, Penin F, Dussaix E, Feray C.
Genetic clustering of hepatitis C virus strains and severity of recurrent
hepatitis after liver transplantation. J Virol 2001;75(23):11292-7.

6. Referências 94
32. Gretch D, Wile M, Gaur L, et al. Donor-recipient match at the HLA-DQB
locus is associated with recrudescence of chronic hepatitis following
liver transplantation for end stage hepatitis C. Hepatology
1993;18(Suppl):108A.
33. Manez R, Mateo R, Tabasco J, Kusne S, Starzl TE, Duquesnoy RJ. The
influence of HLA donor-recipient compatibility on the recurrence of HBV
and HCV hepatitis after liver transplantation. Transplantation
1995;59(4):640-2.
34. Sheiner P, Schwartz M, Mor E, Schluger L. Severe or multiple rejection
episodes are associated with early recurrence of hepatitis C after
orthotopic liver transplantation. Hepatology 1995;21(1):30-34.
35. Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid
SV, et al. Use of OKT3 is associated with early and severe recurrence
of hepatitis C after liver transplantation [see comments]. Am J
Gastroenterol 1997;92(9):1453-7.
36. Berenguer M, Prieto M, Córdoba J, Rayón JM, Carrasco D, Olaso V, et
al. Early development of chronic active hepatitis in recurrent hepatitis C
virus infection after liver transplantation: association with treatment of
rejection. J Hepatol 1998;28(5):756-63.
37. Ghobrial RM, Farmer DG, Baquerizo A, Colquhoun S, Rosen HR,
Yersiz H, et al. Orthotopic liver transplantation for hepatitis C: outcome,
effect of immunosuppression, and causes of retransplantation during an
8-year single-center experience. Ann Surg 1999;229(6):824-31;
discussion 831-3.
38. Ghobrial RM, Steadman R, Gornbein J, Lassman C, Holt CD, Chen P,
et al. A 10-year experience of liver transplantation for hepatitis C:
analysis of factors determining outcome in over 500 patients. Ann Surg
2001;234(3):384-93; discussion 393-4.

7. Referências 95
39. Zervos XA, Weppler D, Fragulidis GP, Torres MB, Nery JR, Khan MF,
et al. Comparison of tacrolimus with microemulsion cyclosporine as
primary immunosuppression in hepatitis C patients after liver
transplantation. Transplantation 1998;65(8):1044-6.
40. Martell M, Esteban J, Quer J, Genesca J, Weiner A, Esteban R, et al.
Hepatitis C virus (HCV) circulates as a population of different but closely
related genomes: quasispecies nature of HCV genome distribution. J
Virol 1992;66:3225-3229.
41. Oshima M, Tsuchiya M, Yagasaki M, Orita T, Hasegawa M, Tomonoh
K, et al. cDNA clones of Japanese hepatitis C virus genomes derived
from a single patient show sequence heterogeneity. J Gen Virol
1991;72(Pt 11):2805-9.
42. Murakawa K, Esumi M, Kato T, Kambara H, Shikata T. Heterogeneity
within the nonstructural protein 5-encoding region of hepatitis C viruses
from a single patient. Gene 1992;117(2):229-32.
43. Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K,
et al. Variable and hypervariable domains are found in the regions of
HCV corresponding to the flavivirus envelope and NS1 proteins and the
pestivirus envelope glycoproteins. Virology 1991;180(2):842-8.
44. Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami M, Ohba K, et
al. Dynamics of genome change in the E2/NS1 region of hepatitis C
virus in vivo. Virology 1993;197(2):659-68.
45. Weiner A, Geysen H, Christopherson C, Hall J, Mason T, Saracco G, et
al. Evidence of immune selection of hepatitis C virus (HCV) putative
envelope glycoprotein variants: potential role in chronic HCV infections.
Proc. Natl. Acad. Sci. 1992;89:3468-72.
46. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C
virus: quasispecies and genotypes. Semin Liver Dis 1995;15(1):41-63.

8. Referências 96
47. Forns X, Purcell RH, Bukh J. Quasispecies in viral persistence and
pathogenesis of hepatitis C virus. Trends Microbiol 1999;7(10):402-10.
48. Delwart E, Shpaer E, Louwagie J, McCutchan E, Grez M, Rubsamen-
Waigmann H, et al. Genetic relationships determined by a DNA
heteroduplex mobility assay; analysis of HIV-1 env genes. Science
1993;262:1257-60.
49. Delwart EL, Herring B, Rodrigo AG, Mullins JI. Genetic subtyping of
human immunodeficiency virus using a heteroduplex mobility assay.
PCR Methods Appl 1995;4(5):S202-16.
50. Pol S, Lamorthe B, Thi NT, Thiers V, Carnot F, Zylberberg H, et al.
Retrospective analysis of the impact of HIV infection and alcohol use on
chronic hepatitis C in a large cohort of drug users [see comments]. J
Hepatol 1998;28(6):945-50.
51. Gretch DR, Polyak SJ, Wilson JJ, Carithers RL, Jr., Perkins JD, Corey
L. Tracking hepatitis C virus quasispecies major and minor variants in
symptomatic and asymptomatic liver transplant recipients. J Virol
1996;70(11):7622-31.
52. Sullivan DG, Wilson JJ, Carithers RL, Jr., Perkins JD, Gretch DR.
Multigene tracking of hepatitis C virus quasispecies after liver
transplantation: correlation of genetic diversification in the envelope
region with asymptomatic or mild disease patterns. J Virol
1998;72(12):10036-43.
53. Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, et
al. Quantitation of hepatitis C virus RNA in liver transplant recipients.
Gastroenterology 1994;106(4):994-9.
54. Yun Z, Barkholt L, Sönnerborg A. Dynamic analysis of hepatitis C virus
polymorphism in patients with orthotopic liver transplantation.
Transplantation 1997;64(1):170-2.

9. Referências 97
55. Ballardini G, De Raffele E, Groff P, Bioulac-Sage P, Grassi A, Ghetti S,
et al. Timing of reinfection and mechanisms of hepatocellular damage in
transplanted hepatitis C virus-reinfected liver. Liver Transpl
2002;8(1):10-20.
56. Guerrero RB, Batts KP, Burgart LJ, Barrett SL, Germer JJ, Poterucha
JJ, et al. Early detection of hepatitis C allograft reinfection after
orthotopic liver transplantation: a molecular and histologic study. Mod
Pathol 2000;13(3):229-37.
57. Doughty AL, Painter DM, McCaughan GW. Nonspecificity of
monoclonal antibody Tordji-22 for the detection of hepatitis C virus in
liver transplant recipients with cholestatic hepatitis. Liver Transpl Surg
1999;5(1):40-5.
58. Scheuer P. Classification of chronic viral hepatitis: a need for
reassessment. J Hepatol 1991;13:372-4.
59. Gayotto L et al. Visão histórica e consenso nacional sobre a
classificação das hepatites crônicas. GED 2000;19(3):137-140.
60. Davidson F, Simmonds P, Ferguson J, Jarvis L, Dow B, Follett A, et al.
Survey of major genotypes and subtypes of hepatitis C using RFLP of
sequences amplified from the 5' non-coding region. J Gen Virol
1995;76:1197-1204.
61. Simmonds P, Alberti A, Alter H, Bonino F, Bradley D, Brechot C, et al. A
proposed system for the nomenclature of hepatitis C virus genotypes.
Hepatology 1994;19(5):1321-4.
62. Alves V, Wakamatsu A, Nonogaki S, Santos R, Stuyvert L, Maertens B,
et al. Hepatitis C - Immunohistochemical detection of HCV core antigen
and possible pathogenic implications. Mod Pathol 1998;2(1):150A.

10. Referências 98
63. Krawczynski K, Beach MJ, Bradley DW, Kuo G, di Bisceglie AM,
Houghton M, et al. Hepatitis C virus antigen in hepatocytes:
immunomorphologic detection and identification. Gastroenterology
1992;103(2):622-9.
64. Pessoa MG, Bzowej N, Berenguer M, Phung Y, Kim M, Ferrell L, et al.
Evolution of hepatitis C virus quasispecies in patients with severe
cholestatic hepatitis after liver transplantation. Hepatology
1999;30(6):1513-20.
65. Berenguer M, Prieto M, Palau A, Rayon JM, Carrasco D, Juan FS, et al.
Severe recurrent hepatitis C after liver retransplantation for hepatitis C
virus-related graft cirrhosis. Liver Transpl 2003;9(3):228-35.
66. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder JC, et al.
The outcome of acute hepatitis C predicted by the evolution of the viral
quasispecies. Science 2000;288(5464):339-44.
67. Nelson DR, Lau JY. Pathogenesis of chronic hepatitis C virus infection.
Antivir Ther 1998;3(Suppl):25-35.
68. Nelson DR, Marousis CG, Ohno T, Davis GL, Lau JY. Intrahepatic
hepatitis C virus-specific cytotoxic T lymphocyte activity and response
to interferon alfa therapy in chronic hepatitis C. Hepatology
1998;28(1):225-30.
69. Hassoba HM, Bzowej N, Berenguer M, Kim M, Zhou S, Phung Y,
Pessôa MG, Wright T. Evolution of viral quasispecies in interferon-
treated patients with chronic hepatitis C virus infection. J Hepatol
1999;31(4):618-27.

11. Referências 99
70. Lopez-Labrador FX, Ampurdanes S, Gimenez-Barcons M, Guilera M,
Costa J, Jimenez de Anta MT, et al. Relationship of the genomic
complexity of hepatitis C virus with liver disease severity and response
to interferon in patients with chronic HCV genotype 1b infection
[correction of interferon]. Hepatology 1999;29(3):897-903.
71. Doughty AL, Painter DM, McCaughan GW. Post-transplant
quasispecies pattern remains stable over time in patients with recurrent
cholestatic hepatitis due to hepatitis C virus. J Hepatol 2000;32(1):126-
34.
72. Doughty AL, Zekry A, Spencer JD, Turhan S, Painter D, McCaughan
GW. Spontaneous clearance of hepatitis C virus infection post-liver
transplantation is associated with rapidly changing quasispecies: a
single case report. Liver Transpl 2000;6(5):648-53.
73. Lyra AC, Fan X, Lang DM, Yusim K, Ramrakhiani S, Brunt EM, et al.
Evolution of hepatitis C viral quasispecies after liver transplantation.
Gastroenterology 2002;123(5):1485-93.
74. McCaughan GW, Doughty A. Posttransplant hepatitis C virus
quasispecies and cholestatic hepatitis. Hepatology 2000;32(5):1182.
75. Sherman KE, Andreatta C, J OB, Gutierrez A, Harris R. Hepatitis C in
human immunodeficiency virus-coinfected patients: increased variability
in the hypervariable envelope coding domain. Hepatology
1996;23(4):688-94.
76. Krawczynski K, Beach M, Di Bisceglie A, Kim J, Alter M, Bradley D, et
al. Hepatocellular HCV-associated antigen and antibody: viral specificity
and relation to natural history of infection. Hepatology 1990;12:905.
77. Roskams T. The role of immunohistochemistry in diagnosis. Clin Liver
Dis 2002;6(2):571-89, x.

12. Referências 100
78. Scheuer PJ, Krawczynski K, Dhillon AP. Histopathology and detection
of hepatitis C virus in liver. Springer Semin Immunopathol
1997;19(1):27-45.
79. Deshpande V, Burd E, Aardema KL, Ma CK, Moonka DK, Brown KA, et
al. High levels of hepatitis C virus RNA in native livers correlate with the
development of cholestatic hepatitis in liver allografts and a poor
outcome. Liver Transpl 2001;7(2):118-24.
80. Zervos X, Weppler D, Berho M, al e. Increased hepatitis C viremia in
cholestatic hepatitis C following orthotopic liver transplantation. Is the
pathogenicity of the syndrome related to viral cytopathic mechanisms?
Transplantation 1998;65(Suppl):181A.